Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy
Authors
Keywords
-
Journal
EPILEPSY RESEARCH
Volume 195, Issue -, Pages 107185
Publisher
Elsevier BV
Online
2023-07-06
DOI
10.1016/j.eplepsyres.2023.107185
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
- (2022) Pavel Klein et al. NEUROLOGY
- Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
- (2022) Michael C. Smith et al. Neurology and Therapy
- Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability
- (2021) Roberta Roberti et al. CNS DRUGS
- Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
- (2021) Jacqueline A. French et al. EPILEPSIA
- Effect of cenobamate on the single‐dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjects
- (2021) Stephen A. Greene et al. CTS-Clinical and Translational Science
- Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese
- (2021) Eunsol Yang et al. CTS-Clinical and Translational Science
- Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
- (2021) William E. Rosenfeld et al. EPILEPSIA
- Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects
- (2020) Laurent Vernillet et al. Clinical Pharmacology in Drug Development
- Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
- (2020) Michael R. Sperling et al. EPILEPSIA
- Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
- (2020) Steve S. Chung et al. NEUROLOGY
- Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
- (2019) Gregory L Krauss et al. LANCET NEUROLOGY
- Drug development for refractory epilepsy: The past 25 years and beyond
- (2017) Ambica Golyala et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Is a separate monotherapy indication warranted for antiepileptic drugs?
- (2015) Scott Mintzer et al. LANCET NEUROLOGY
- Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
- (2009) Erik St. Louis et al. Current Neuropharmacology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now